Cargando…

A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis

Anti-cytokine therapeutic antibodies have been demonstrated to be effective in the treatment of several auto-immune disorders. However, The problems in antibody manufacture and the immunogenicity caused by multiple doses of antibodies inspire people to use auto-cytokine as immunogen to induce anti-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Changzhen, Zhao, Yunfeng, He, Wen, Wang, Wei, Chen, Yuan, Zhang, Shiqian, Ma, Yijing, Gohda, Jin, Ishida, Takaomi, Walter, Thomas S., Owens, Raymond J., Stuart, David I., Ren, Jingshan, Gao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585926/ https://www.ncbi.nlm.nih.gov/pubmed/26412210 http://dx.doi.org/10.1038/srep14150

Ejemplares similares

Role of RANKL inhibition in osteoporosis
por: McClung, Michael
Publicado: (2007)

Inhibition of RANKL-Induced Osteoclastogenesis by Novel Mutant RANKL
por: Jang, Yuria, et al.
Publicado: (2021)

RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis
por: Morgans, Alicia K., et al.
Publicado: (2011)

Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis
por: Wang, Peng, et al.
Publicado: (2018)

Icaritin ameliorates RANKL-mediated osteoclastogenesis and ovariectomy-induced osteoporosis
por: Huang, Jun-ming, et al.
Publicado: (2023)

Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
por: Huang, Dane, et al.
Publicado: (2022)

Pros and Cons of Denosumab Treatment for Osteoporosis and Implication for RANKL Aptamer Therapy
por: Zhang, Ning, et al.
Publicado: (2020)

Association of RANKL and OPG Gene Polymorphism in Arab Women with and without Osteoporosis
por: Abdi, Saba, et al.
Publicado: (2021)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

Notopterol Attenuates Estrogen Deficiency-Induced Osteoporosis via Repressing RANKL Signaling and Reactive Oxygen Species
por: Chen, Delong, et al.
Publicado: (2021)

Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis
por: Wang, Qingqing, et al.
Publicado: (2018)

Maternal RANKL Reduces the Osteopetrotic Phenotype of Null Mutant Mouse Pups
por: Navet, Benjamin, et al.
Publicado: (2018)

Origins of Alterations to Rankl Null Mutant Mouse Dental Root Development
por: Gama, Andrea, et al.
Publicado: (2020)

Disturbance of the OPG/RANK/RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis
por: Bai, Peng, et al.
Publicado: (2011)

Serum β-Catenin Levels Associated with the Ratio of RANKL/OPG in Patients with Postmenopausal Osteoporosis
por: Xu, Xiao-Juan, et al.
Publicado: (2013)

Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling
por: Xia, Wen-Fang, et al.
Publicado: (2013)

Baicalin Ameliorates Dexamethasone-Induced Osteoporosis by Regulation of the RANK/RANKL/OPG Signaling Pathway
por: Zhao, Ye, et al.
Publicado: (2020)

QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism
por: Du, Tianshu, et al.
Publicado: (2020)

Cryptotanshinone Suppressed Postmenopausal Osteoporosis by Preventing RANKL-Mediated Osteoclastogenesis against Kidney Injury
por: Yang, Wenjiu, et al.
Publicado: (2022)

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro
por: Zhang, Shiqian, et al.
Publicado: (2017)

A novel RANKL‐targeted flavonoid glycoside prevents osteoporosis through inhibiting NFATc1 and reactive oxygen species
por: Hong, Guoju, et al.
Publicado: (2021)

Beneficial effect of pristimerin against the development of osteoporosis in ovariectomy-induced osteoporosis rats by the RANKL/TRAF6/NF-κB pathway
por: Xu, Wei, et al.
Publicado: (2019)

The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis
por: Weitzmann, M. Neale
Publicado: (2013)

Effects of RANKL Knockdown by Virus-like Particle-Mediated RNAi in a Rat Model of Osteoporosis
por: Hoffmann, Daniel B., et al.
Publicado: (2018)

Sex-determining region Y (SRY) attributes to gender differences in RANKL expression and incidence of osteoporosis
por: Kodrič, Klemen, et al.
Publicado: (2019)

A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor
por: Ko, Young Jong, et al.
Publicado: (2021)

HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro
por: Gohda, Jin, et al.
Publicado: (2015)

Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling
por: Bartelt, Alexander, et al.
Publicado: (2018)

Beneficial effects of Cuscuta chinensis extract on glucocorticoid-induced osteoporosis through modulation of RANKL/OPG signals
por: Mo, Hui, et al.
Publicado: (2019)

Administration of zoledronic acid alleviates osteoporosis in HIV patients by suppressing osteoclastogenesis via regulating RANKL expression
por: Lin, Wei, et al.
Publicado: (2021)

Lactobacillus plantarum LP45 inhibits the RANKL/OPG signaling pathway and prevents glucocorticoid-induced osteoporosis
por: Jiang, Xiaofeng, et al.
Publicado: (2023)

Loureirin B suppresses RANKL-induced osteoclastogenesis and ovariectomized osteoporosis via attenuating NFATc1 and ROS activities
por: Liu, Yuhao, et al.
Publicado: (2019)

Macrophages Switch to an Osteo‐Modulatory Profile Upon RANKL Induction in a Medaka (Oryzias latipes) Osteoporosis Model
por: Phan, Quang Tien, et al.
Publicado: (2020)

Norlichexanthone purified from plant endophyte prevents postmenopausal osteoporosis by targeting ERα to inhibit RANKL signaling
por: Wang, Keqi, et al.
Publicado: (2021)

Ginsenoside compound-K attenuates OVX-induced osteoporosis via the suppression of RANKL-induced osteoclastogenesis and oxidative stress
por: Ding, Lingli, et al.
Publicado: (2023)

Creation of RANKL mutants with low affinity for decoy receptor OPG and their potential anti‐fibrosis activity
por: Wang, Yizhou, et al.
Publicado: (2019)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

From discovery of RANKL to clinical application of anti-human RANKL antibody
por: Yasuda, Hisataka, et al.
Publicado: (2012)

RANKL Expression in Periodontal Disease: Where Does RANKL Come from?
por: Chen, Bin, et al.
Publicado: (2014)

BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l2i89m15680v1gjoeoblvpnpta